Cargando…

Cognitive behaviour therapy for schizophrenia

Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impair...

Descripción completa

Detalles Bibliográficos
Autores principales: Addington, Jean, Lecomte, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292287/
https://www.ncbi.nlm.nih.gov/pubmed/22403587
http://dx.doi.org/10.3410/M4-6
_version_ 1782225255754891264
author Addington, Jean
Lecomte, Tania
author_facet Addington, Jean
Lecomte, Tania
author_sort Addington, Jean
collection PubMed
description Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impaired. All the evidence suggests that individuals with schizophrenia do best with a combination of pharmacological and psychosocial intervention. One psychosocial treatment that has received much attention is cognitive behaviour therapy (CBT). This brief review will address what we know about the use and effectiveness of CBT at all phases of schizophrenia and its strengths, weaknesses and its future.
format Online
Article
Text
id pubmed-3292287
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-32922872012-03-08 Cognitive behaviour therapy for schizophrenia Addington, Jean Lecomte, Tania F1000 Med Rep Review Article Schizophrenia is one of the major and potentially severe mental illnesses. Even with best practices, there are limitations to the effectiveness of treatments that include medications for this disorder. Relapse rates are high and often those with the illness remain symptomatic and functionally impaired. All the evidence suggests that individuals with schizophrenia do best with a combination of pharmacological and psychosocial intervention. One psychosocial treatment that has received much attention is cognitive behaviour therapy (CBT). This brief review will address what we know about the use and effectiveness of CBT at all phases of schizophrenia and its strengths, weaknesses and its future. Faculty of 1000 Ltd 2012-03-01 /pmc/articles/PMC3292287/ /pubmed/22403587 http://dx.doi.org/10.3410/M4-6 Text en © 2012 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Addington, Jean
Lecomte, Tania
Cognitive behaviour therapy for schizophrenia
title Cognitive behaviour therapy for schizophrenia
title_full Cognitive behaviour therapy for schizophrenia
title_fullStr Cognitive behaviour therapy for schizophrenia
title_full_unstemmed Cognitive behaviour therapy for schizophrenia
title_short Cognitive behaviour therapy for schizophrenia
title_sort cognitive behaviour therapy for schizophrenia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292287/
https://www.ncbi.nlm.nih.gov/pubmed/22403587
http://dx.doi.org/10.3410/M4-6
work_keys_str_mv AT addingtonjean cognitivebehaviourtherapyforschizophrenia
AT lecomtetania cognitivebehaviourtherapyforschizophrenia